Biotech6 hours ago
Akribion Therapeutics Secures €8M to Advance CRISPR-Based Cell Depletion Technology
CRISPR specialist Akribion Therapeutics, a 2024 spin-off from BRAIN Biotech, raised €8M in seed funding led by CARMA FUND and RV Invest. The funds will support...